Prevention and treatment of amyloidogenic disease

Details for Australian Patent Application No. 2006202899 (hide)

International Classifications

Event Publications

27 July 2006 Application Open to Public Inspection

Published as AU-B-2006202899

27 July 2006 Complete Application Filed

9 July 2009 Assignment before Grant

Neuralab Limited The application has been assigned to Elan Pharma International Limited

29 October 2009 Application Accepted

Published as AU-B-2006202899

25 February 2010 Standard Patent Sealed

22 April 2010 Assignment Registered

Elan Pharma International Limited The patent has been assigned to Janssen Alzheimer Immunotherapy

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.